Table 1.
Included studies.
| No | Study | Trial Name | Participants (Infants) |
School-Age Outcomes |
Short-Term Outcomes |
Notes |
|---|---|---|---|---|---|---|
| 1 | Crowther 2003 [7] | ACTOMgSO4 | 1255 | ○ | Adopted in Cochrane review published in 2009 |
|
| 2 | Marret 2006 [8] | PREMAG | 688 | ○ | Adopted in Cochrane review published in 2009 |
|
| 3 | Mittrendorf 2002 [24] | MAGNET | 59 | ○ | Adopted in Cochrane review published in 2009 |
|
| 4 | Rouse 2008 [10] | BEAM | 2444 | ○ | Adopted in Cochrane review published in 2009 |
|
| 5 | Doyle 2014 [18] | 669 | ○ | School-age outcomes of No.1 | ||
| 6 | Chollat 2014 [19] | 431 | ○ | School-age outcomes of No.2 | ||
| 7 | Paradidis 2012 [20] | 132 | ○ | Single center analysis of No.1 | ||
| 8 | Drassinower 2015 [21] | 1047 | ○ | Secondary analysis of No.4 | ||
| 9 | Colon 2016 [22] | 31 | ○ | |||
| 10 | Wolf 2020 [23] | 680 | ○ |
ACTOMgSO4; Australasian Collaborative Trial of Magnesium Sulphate; PREMAG; PREterm brain protection by MAGnesium sulphate; MAGNET; Magnesium and Neurologic Endpoints Trial; BEAM; Beneficial Effects of Antenatal Magnesium Sulphate.